Image credit: Canva
Diffuse midline gliomas are the most aggressive brain tumors of children and young adults: many people with these tumors survive less than two years. A clinical trial led by Sadhana Jackson, M.D., Adjunct Investigator in the Pediatric Oncology Branch, is researching a drug therapy for such brain tumors. The trial will take place at the NIH Clinical Center in Bethesda, Maryland, and there is no cost for participation.
For more information, please contact Maggie Fagan at (240) 551-3118 or margaret.fagan@nih.gov
Clinicaltrials.gov identifier: NCT05413304
NCI Protocol ID: 22-C-0003
Official Title: Feasibility of Evaluating Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis
The Center for Cancer Research is NCI’s internal cancer center, a publicly funded organization working to improve the lives of cancer patients by solving important, challenging and neglected problems in cancer research and patient care. Highly trained physician-scientists develop and carry out clinical trials to create the medicines of tomorrow treating patients at the world’s largest dedicated research hospital on the campus of the National Institutes of Health in Bethesda, Maryland.
For more information on CCR clinical trials click here, and subscribe to have the latest CCR clinical trials sent directly to your inbox.
